EMD Serono, Inc. is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people’s lives.
EMD Serono is focused on strengthening its position across its core therapeutic areas of neurodegenerative diseases, fertility and metabolic endocrinology, while growing its presence and expertise within new areas, including oncology and autoimmune diseases.
EMD Serono recently announced plans to construct a state-of-the-art research facility in Massachusetts, creating critical mass in research with a common goal of finding new treatments for unmet medical needs.